214 related articles for article (PubMed ID: 34667751)
41. Two cases of unilateral ashy dermatosis.
Imanishi H; Tsuruta D; Kobayashi H; Ishii M; Nakagawa K
Case Rep Dermatol; 2011 Jan; 3(1):1-4. PubMed ID: 21897817
[TBL] [Abstract][Full Text] [Related]
42. Ashy Dermatosis and Lichen Planus Pigmentosus: The Histopathological Differences.
Rutnin S; Udompanich S; Pratumchart N; Harnchoowong S; Vachiramon V
Biomed Res Int; 2019; 2019():5829185. PubMed ID: 31781623
[TBL] [Abstract][Full Text] [Related]
43. Erythema Dyschromicum Perstans: Identical to Ashy Dermatosis or Not?
Numata T; Harada K; Tsuboi R; Mitsuhashi Y
Case Rep Dermatol; 2015; 7(2):146-50. PubMed ID: 26351421
[TBL] [Abstract][Full Text] [Related]
44. Multiple linear erythema dyschromicum perstans (ashy dermatosis) in the lines of Blaschko.
Yokozeki H; Ueno M; Komori K; Nishioka K
Dermatology; 2005; 210(4):356-7. PubMed ID: 15942229
[No Abstract] [Full Text] [Related]
45. A case of Cinderella: erythema dyschromicum perstans (ashy dermatosis or dermatosis cinecienta).
Muñoz C; Chang AL
Skinmed; 2011; 9(1):63-4. PubMed ID: 21409966
[TBL] [Abstract][Full Text] [Related]
46. Riehl's melanosis.
rorsman H
Int J Dermatol; 1982 Mar; 21(2):75-8. PubMed ID: 7068304
[TBL] [Abstract][Full Text] [Related]
47. Clinical and histological aspect of erythema dyschromicum perstans in Korea: A review of 68 cases.
Chang SE; Kim HW; Shin JM; Lee JH; Na JI; Roh MR; Lee JH; Lee GY; Ko JY
J Dermatol; 2015 Nov; 42(11):1053-7. PubMed ID: 26118942
[TBL] [Abstract][Full Text] [Related]
48. Ribociclib-Induced Erythema Dyschromicum Perstans (Ashy Dermatosis)-Like Pigmentation in a Metastatic Breast Cancer Patient.
Mariano M; Donati P; Cameli N; Pigliacelli F; Morrone A; Cristaudo A
J Breast Cancer; 2021 Feb; 24(1):117-121. PubMed ID: 33634626
[TBL] [Abstract][Full Text] [Related]
49. Contact sensitization to Magnolia officinalis bark extract and other allergens in a patient with frontal fibrosing alopecia and lichen planus pigmentosus.
Gatica-Ortega ME; Pastor-Nieto MA; Torres-Aranda R; Alonso-Naranjo L; Pérez-Hortet C
Contact Dermatitis; 2022 May; 86(5):434-436. PubMed ID: 35076106
[No Abstract] [Full Text] [Related]
50. Optimizing Q-switched lasers for melasma and acquired dermal melanoses.
Aurangabadkar SJ
Indian J Dermatol Venereol Leprol; 2019; 85(1):10-17. PubMed ID: 30027914
[TBL] [Abstract][Full Text] [Related]
51. Idiopathic eruptive macular pigmentation with papillomatosis: Report of nine cases.
Joshi R
Indian J Dermatol Venereol Leprol; 2007; 73(6):402-5. PubMed ID: 18032859
[TBL] [Abstract][Full Text] [Related]
52. Erythema dyschromicum perstans and lichen planus.
Naidorf KF; Cohen SR
Arch Dermatol; 1982 Sep; 118(9):683-5. PubMed ID: 7114873
[TBL] [Abstract][Full Text] [Related]
53. Lichen planus pigmentosus.
Rieder E; Kaplan J; Kamino H; Sanchez M; Pomeranz MK
Dermatol Online J; 2013 Dec; 19(12):20713. PubMed ID: 24365004
[TBL] [Abstract][Full Text] [Related]
54. Relevant sensitization to diethylamino hydroxybenzoyl hexyl benzoate and fragrances in a patient with frontal fibrosing alopecia and acquired dermal macular hyperpigmentation.
Gatica-Ortega ME; Vergara-de-la-Campa L; Alonso-Naranjo L; Pastor-Nieto MA
Contact Dermatitis; 2022 Sep; 87(3):287-289. PubMed ID: 35506507
[No Abstract] [Full Text] [Related]
55. [Chronic toxic erythemo-macular skin hyperpigmentation (erythema dyschromicum perstans, ashy dermatosis].
Samos-Zielińska J; Lańcucki J; Dabrowski J; Sadowska-Iwańciow H
Przegl Dermatol; 1979; 66(4):385-91. PubMed ID: 493562
[No Abstract] [Full Text] [Related]
56. Combination therapy with prednisone and isotretinoin in early erythema dyschromicum perstans: A retrospective series.
Diaz A; Gillihan R; Motaparthi K; Rees A
JAAD Case Rep; 2020 Mar; 6(3):207-213. PubMed ID: 32149180
[No Abstract] [Full Text] [Related]
57. Chlorothalonil, a possible cause of erythema dyschromicum perstans (ashy dermatitis).
Penagos H; Jimenez V; Fallas V; O'Malley M; Maibach HI
Contact Dermatitis; 1996 Oct; 35(4):214-8. PubMed ID: 8957640
[TBL] [Abstract][Full Text] [Related]
58. Clinical profile of 300 men with facial hypermelanosis.
Gupta M; Mahajan VK
J Dermatol Case Rep; 2017 Dec; 11(2):20-24. PubMed ID: 29367869
[TBL] [Abstract][Full Text] [Related]
59. Non-ablative 1550 nm fractional laser therapy not effective for erythema dyschromicum perstans and postinflammatory hyperpigmentation: a pilot study.
Kroon MW; Wind BS; Meesters AA; Wolkerstorfer A; van der Veen JP; Bos JD; Van der Wal AC; Beek JF
J Dermatolog Treat; 2012 Oct; 23(5):339-44. PubMed ID: 21756152
[TBL] [Abstract][Full Text] [Related]
60. Pigmentary problems in the tropics.
Dominguez-Soto L; Hojyo-Tomoka T; Vega-Memije E; Arenas R; Cores-Franco R
Dermatol Clin; 1994 Oct; 12(4):777-84. PubMed ID: 7805307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
